SCHEMBL13288997

SCHEMBL13288997

Bc1cnn2c(NCCNS(=O)(=O)c3ccc(OC)cc3)cc(-c3ccccc3Cl)nc12

nearest known ligand 0.49

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
▸ ALDH1A1 P00352 6/20 0.49
▸ GSK3B P49841 4/20 0.46
▸ CDK2 P24941 3/20 0.43
▸ GSR P00390 3/20 0.40
▸ POLB P06746 2/20 0.39
▸ PKM P14618 1/20 0.38
▸ RAF1 P04049 1/20 0.37
▸ BRAF P15056 1/20 0.37
▸ MEN1 O00255 1/20 0.37
▸ KMT2A Q03164 1/20 0.37
▸ SMN1; SMN2 Q16637 1/20 0.36
▸ HTR7 P34969 1/20 0.36
▸ CYP1A2 P05177 1/20 0.36
▸ CYP3A4 P08684 1/20 0.36
▸ CYP2D6 P10635 1/20 0.36
▸ MAPT P10636 1/20 0.36
▸ CYP2C19 P33261 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13289501 0.95 ALDH1A1 (0.47) ALDH1A1GSK3BCDK2GSRPOLB
SCHEMBL13289274 0.92 GSK3B (0.46) ALDH1A1GSK3BCDK2GSRRAF1
SCHEMBL14546013 0.92 GSK3B (0.47) ALDH1A1GSK3BCDK2POLBKMT2A
SCHEMBL13289272 0.91 GSK3B (0.48) ALDH1A1GSK3BCDK2POLBMEN1
SCHEMBL13289118 0.91 GSK3B (0.56) ALDH1A1GSK3BCDK2POLBPKM
SCHEMBL13289126 0.91 GSK3B (0.47) ALDH1A1GSK3BCDK2POLBPKM
SCHEMBL13289394 0.90 GSK3B (0.44) ALDH1A1GSK3BCDK2POLBKMT2A
SCHEMBL13121229 0.90 GSK3B (0.59) ALDH1A1GSK3BCDK2GSRPOLB
SCHEMBL13289384 0.89 GSK3B (0.47) ALDH1A1GSK3BCDK2POLBPKM
SCHEMBL13289506 0.89 GSK3B (0.47) ALDH1A1GSK3BCDK2POLBPKM

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2194058-A1 Pyrazolopyrimidines suitable for the treatment of cancer diseases SCHERING CORPORATION (US) 2010-06-09 — — EP disclosed
Send feedback